Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2005-07-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.ACCREVIEW.2005.09.030PMID 16030277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study

  2007cited by this paper
• C-Reactive Protein Levels and Outcomes After Statin Therapy

  2006cited by this paper
• A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women

  2006cited by this paper
• C-reactive protein levels and outcomes after statin therapy.

  2005cited by this paper
• Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer The Women ’ s Health Study : A Randomized Controlled Trial

  2005cited by this paper
• Low-Dose Aspirin Does Not Reduce Cancer Incidence in Women Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55.

  2005cited by this paper
• Effects of estrogen with and without progestin on urinary incontinence

  2005cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.

  2005cited by this paper
• Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.

  2005cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004influential reference
• C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany

  2004cited by this paper
• Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

  2004cited by this paper
• Multivariate Assessment of Lipid Parameters as Predictors of Coronary Heart Disease Among Postmenopausal Women: Potential Implications for Clinical Guidelines

  2004cited by this paper
• Inflammatory markers and the risk of coronary heart disease in men and women.

  2004cited by this paper
• MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION

  2003influential reference
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

  2003cited by this paper
• Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

  2003cited by this paper
• Cholesterol measures to identify and treat individuals at risk for coronary heart disease.

  2003cited by this paper
• C-reactive protein is an independent predictor of risk for the development of diabetes mellitus in the West of Scotland Coronary Prevention Study

  2002cited by this paper
• C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

  2002cited by this paper
• Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002cited by this paper
• Nonfasting Apolipoprotein B and Triglyceride Levels as a Useful Predictor of Coronary Heart Disease Risk in Middle-Aged UK Men

  2002influential reference
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2.

  2001cited by this paper
• Coronary Heart Disease Prediction From Lipoprotein Cholesterol Levels, Triglycerides, Lipoprotein(a), Apolipoproteins A-I and B, and HDL Density Subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

  2001cited by this paper
• Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

  2001cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.

  2001influential reference
• Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Apolipoprotein Concentrations During Treatment and Recurrent Coronary Artery Disease Events

  2000cited by this paper
• Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications.

  2000cited by this paper
• Thrombogenic factors and recurrent coronary events.

  1999cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

  1996influential reference
• Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?

  1995cited by this paper
• Cholesterol and Coronary Heart Disease: Predicting Risks by Levels and Ratios

  1994cited by this paper
• A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

  1991cited by this paper
• Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum.

  1986cited by this paper

• Identifying metabolic parameters as key indicators of hyperuricemia and ischemic stroke comorbidity via interpretable Clinlabomics models

  2026cites this paper
• Ultra-processed food consumption and its association with the atherogenic index of plasma and blood lipid profile in adults: a cohort-based cross-sectional study

  2026cites this paper
• Role of Lipids and Lipid Management Therapy Among Patients With Peripheral Artery Disease: A Reappraisal of the Current Evidence and Future Directions

  2025cites this paper
• The relationship between adherence to the Mediterranean diet, quality of life, anthropometric measurements, and some biochemical parameters in patients with coronary artery disease.

  2025cites this paper
• Non-HDL-C and non-HDL-C/HDL-C ratio as predictors of hepatic steatosis: a systematic review and meta-analysis

  2025cites this paper
• Lipid profiles, lipid ratios and 28-day mortality risk in non-surgical older patients with critical illnesses: a retrospective cohort study using hospitalization records

  2025cites this paper
• Omega-3 fatty acids and cardiovascular risk-related metabolic markers in diverse populations: a meta-analysis of randomized trials.

  2025cites this paper
• The Role of Non-HDL Cholesterol and Apolipoprotein B in Cardiovascular Disease: A Comprehensive Review

  2025cites this paper
• Assessment of environmental pollutant exposure and cardiovascular risk in Mexican brick-making communities

  2025cites this paper
• Association of LDL‐C/HDL‐C Ratio With Hyperuricemia: A National Cohort Study

  2025cites this paper
• Lipoprotein Ratios: Correlations With Glycated Hemoglobin Among Type 2 Diabetes Mellitus Patients

  2024cites this paper
• Association between atherogenic indexes and erectile dysfunction: a cross-sectional analysis of the National Health and Nutrition Examination Survey 2001–2004

  2024cites this paper
• Glycated Hemoglobin as a Predictor of Dyslipidemia and Cardiovascular Risk in Type 2 Diabetes Mellitus

  2024cites this paper
• The Influence of Non-High-Density Lipoprotein Cholesterol on the Efficacy of Genotype-Guided Dual Antiplatelet Therapy in Preventing Stroke Recurrence

  2024cites this paper
• Predictive value of total cholesterol to high‐density lipoprotein cholesterol ratio for chronic kidney disease among adult male and female in Northwest China

  2024cites this paper
• Clinical Significance of the Lipid Profile Ratios and Triglyceride Glucose Index in the Diagnosis of Metabolic Syndrome

  2024cites this paper
• Morning physical activity may be more beneficial for blood lipids than afternoon physical activity in older adults: a cross-sectional study

  2024cites this paper
• Association of HDL cholesterol with all-cause and cardiovascular mortality in primary hypercholesterolemia.

  2024cites this paper
• The roles of lipids and inflammation in the association between the triglyceride-glucose index and arterial stiffness: evidence from two large population-based surveys

  2024cites this paper
• Atherogenic Index as a Cardiovascular Biomarker in Mexican Workers from Marginalized Urban Areas Occupationally Exposed to Metals.

  2024cites this paper
• Association of albumin to non-high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients

  2024cites this paper
• Inverse relationship between LDL-C/HDL-C ratio and atrial fibrillation in chronic kidney disease patients

  2024cites this paper
• The relevance of remnant cholesterol as a guide for lipid management in Indian subjects undergoing coronary revascularization.

  2024cites this paper
• THE STATE OF LIPID METABOLISM IN PATIENTS WITH DIABETIC NEPHROPATHY

  2024cites this paper
• Effect Of Ramadhan Fasting On Apolipoprotein B And Small Dense Ldl In Type 2 Diabetes Mellitus Patients

  2024influential citation
• Atherogenic Combined Index: Validation of a Novel Predictive Lipid Biomarker for the Presence and Severity of Coronary Artery Disease.

  2024cites this paper
• Non-HDL-C, Symptomatic Intracranial Arterial Stenosis, and Recurrent Vascular Risk in Minor Stroke

  2024cites this paper
• Lipid-Lowering Therapy in PURE Poland Cohort Study

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• Clinical competence, communication ability and adherence to choosing wisely recommendations for lipid reducing drug use in older adults

  2023cites this paper
• Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms

  2023cites this paper
• Increased Plasma Non-High-Density Lipoprotein Levels and Poor Coronary Collateral Circulation in Patients With Stable Coronary Artery Disease.

  2023cites this paper
• Assessing the timing and the duration of exposure to air pollution on cardiometabolic biomarkers in patients suspected of coronary artery disease.

  2023cites this paper
• Association of Cardiovascular Health With Life Expectancy Free of Cardiovascular Disease, Diabetes, Cancer, and Dementia in UK Adults.

  2023cites this paper
• Atherogenesis in Apoe−/− and Ldlr−/− Mice with a Genetically Resistant Background

  2023cites this paper
• Residual Atherosclerotic Cardiovascular Disease Risk: Focus on Non-High-Density Lipoprotein Cholesterol

  2023influential citation
• Familial Hyperlipidemia Caused by Apolipoprotein B Mutation in the Pediatric Amish Population: A Mini Review.

  2023cites this paper
• The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population

  2023cites this paper
• Higher Non-High-Density Lipoprotein Cholesterol Was Higher Associated With Cardiovascular Disease Comparing Higher LDL-C in Nine Years Follow Up: Cohort Study

  2023cites this paper
• Factors to Consider with Estimated Low-density Lipoprotein Cholesterol using the New Sampson-NIH Equation.

  2023cites this paper
• Consecutive reference intervals for biochemical indices related to serum lipid levels and renal function during normal pregnancy

  2022cites this paper
• Emerging Markers for Cardiovascular Risk Assessment

  2022cites this paper
• LipidClock: A Lipid-Based Predictor of Biological Age

  2022cites this paper
• Dyslipidemia in South African patients with hypothyroidism

  2022cites this paper
• The association between non-HDL cholesterol and SYNTAX score in premature heart disease

  2022cites this paper
• Association of Carotid Intima-Media Thickness and Plague with Lipid Profiles in a High-Stroke Risk Population

  2022cites this paper
• Nutritional Health in Premenopausal Women: A Cross-Sectional Study from Turkey

  2022cites this paper
• Novel Biomarkers in Risk Assessment and Management of Hyperlipidemia in Cardiovascular Disease

  2022cites this paper
• Associations of lipid measures with total occlusion in patients with established coronary artery disease: a cross-sectional study

  2022cites this paper
• Molecular Biological and Clinical Understanding of the Statin Residual Cardiovascular Disease Risk and Peroxisome Proliferator-Activated Receptor Alpha Agonists and Ezetimibe for Its Treatment

  2022cites this paper
• Markers of Maternal Insulin Resistance and Lipid Ratios Measured in Early Pregnancy Are Related to Adverse Fetomaternal Outcomes in Women Treated for Hyperglycemia Detected in Early Pregnancy—Data from a Retrospective Cohort Study

  2022cites this paper
• Discordance of Apolipoprotein B, Non-HDL-Cholesterol, and LDL-Cholesterol Predicts Risk of Increased Arterial Stiffness and Elevated Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese Adults

  2022cites this paper
• Markers of Oxidative Stress, Inflammation, and Endothelial Dysfunction in Diabetic and Nondiabetic Patients with Chronic Kidney Disease on Peritoneal Dialysis

  2022cites this paper
• Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B

  2022cites this paper
• Laboratory and anthropometric parameters in the assessment of the risk of cardiovascular disease

  2022cites this paper
• Metabolic syndrome, associated factors and optimal waist circumference cut points: findings from a cross-sectional community-based study in the elderly population in Asmara, Eritrea

  2022cites this paper
• Lack of Evidence for a Relationship Between Salivary CRP and Women's Sexual Desire: An Investigation Across Clinical and Healthy Samples.

  2022cites this paper
• TG/HDL, Non-HDL, and TyG index as predictive parameters for CVDs in uncontrolled diabetic patients better than LDL-C and LDL/HDL ratio

  2022cites this paper
• Differential effects of hyperhomocysteinemia on the lipid profiles and lipid ratios between patients with and without coronary artery disease: A retrospective observational study

  2022cites this paper
• Atherogenic indices in pediatric population in South-Southeast region of Mexico.

  2022cites this paper
• Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US Adults

  2022cites this paper
• Dyslipidemia and 10-year diabetes incidence in Japanese people: Population-based Panasonic cohort study 9

  2022cites this paper
• Triglyceride Levels with Coronary Artery Disease

  2022cites this paper
• The effect of total cholesterol/high-density lipoprotein cholesterol ratio on mortality risk in the general population

  2022cites this paper
• Association between atherogenic index of plasma and left ventricular hypertrophy in patients with chronic heart failure with mid-range ejection fraction

  2022cites this paper
• Combined Associations of Serum Ferritin and Body Size Phenotypes With Cardiovascular Risk Profiles: A Chinese Population-Based Study

  2021cites this paper
• Total cholesterol/HDL-C ratio versus non-HDL-C as predictors for ischemic heart disease: a 17-year follow-up study of women in southern Sweden

  2021cites this paper
• ASSOCIATIONS BETWEEN PATHOGENETIC FACTORS OF METABOLIC AND CIRCULATORY SYNDROMES IN YOUNG ADULTS IN A RUSSIAN ARCTIC CITY

  2021cites this paper
• Higher Serum Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio Is Associated with Increased Mortality among Incident Peritoneal Dialysis Patients

  2021cites this paper
• The Effect of The Oil Consumption Pattern on Atherogenic Index of Plasma: Evidence From a Cohort Study in West of Iran

  2021cites this paper
• Joint effect of multiple air pollutants on lipid profiles in obese and normal-weight young adults: The key role of ozone.

  2021cites this paper
• LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker

  2021cites this paper
• Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes

  2021cites this paper
• Determining the Relationship between Non- HDL Cholesterol and Syntax Score in Patients with Acute Coronary Syndrome Under 45 Years of Age

  2021cites this paper
• The association of lipid ratios with hyperuricemia in a rural Chinese hypertensive population

  2021cites this paper
• Non-high-density lipoprotein cholesterol and mortality among peritoneal dialysis patients.

  2021cites this paper
• The role of diet and obesity in the association between depression and cardiovascular disease

  2021cites this paper
• Non–High-Density Lipoprotein Cholesterol Predicts Adverse Outcomes in Acute Ischemic Stroke

  2021cites this paper
• Antihyperlipidemic Effects of Methanol Extract of Seeds of Citrullus lanatus in Hyperlipidemic Rats

  2021cites this paper
• The Link between Periodontal Inflammation and Cardiovascular Disease: The Relative Role of the Host Response

  2021cites this paper
• Biological changes in the pregnancy-postpartum period and subsequent cardiometabolic risk-UPSIDE MOMS: A research protocol.

  2021cites this paper
• Effects of social support in an academic context on low-grade inflammation in high school students

  2021cites this paper
• Non-HDL-C Is More Stable Than LDL-C in Assessing the Percent Attainment of Non-fasting Lipid for Coronary Heart Disease Patients

  2020cites this paper
• Cardiovascular Disease in Women: Focus on Lipid Management

  2020cites this paper
• Impacto dos Índices Aterogênicos em Estenose do Enxerto de Veia Safena

  2020cites this paper
• Prevalence of hypertriglyceridemia in adults and related cardiometabolic factors. SIMETAP-HTG study

  2020cites this paper
• Primary Prevention of Coronary Artery Disease

  2020cites this paper
• Association of lowering apolipoprotein B with cardiovascular outcomes across various lipid-lowering therapies: Systematic review and meta-analysis of trials

  2020cites this paper
• Relationship between Hyperlipidemia, Cardiovascular Disease and Stroke: A Systematic Review

  2020cites this paper
• Effect of Quercus infectoria and Zataria multiflora extracts on the expression of Apo-B100 and PPAR-α in liver and adipose tissues in insulin resistant rats

  2020cites this paper
• Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation

  2020cites this paper
• Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®).

  2020cites this paper
• Consensus document of an expert group from the Spanish Society of Arteriosclerosis (SEA) on the clinical use of nuclear magnetic resonance to assess lipoprotein metabolism (Liposcale®)

  2020cites this paper
• Documento de consenso de un grupo de expertos de la Sociedad Española de Arteriosclerosis (SEA) sobre el uso clínico de la resonancia magnética nuclear en el estudio del metabolismo lipoproteico (Liposcale)

  2020cites this paper
• Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации, VII пересмотр

  2020cites this paper
• What is the Impact of Sex on Cardiovascular Disease Risk Factors in Patients with Chronic Kidney Diseases in China: A Cross-sectional Study

  2020cites this paper
• A U-shaped association between the LDL-cholesterol to HDL-cholesterol ratio and all-cause mortality in elderly hypertensive patients: a prospective cohort study

  2020cites this paper
• Serum oestradiol levels are inversely associated with C-reactive protein levels in premenopausal women, but not postmenopausal women

  2020cites this paper
• Impact of Atherogenic Indexes in Saphenous Vein Graft Stenosis.

  2020cites this paper
• Relative effect of hypertriglyceridemia on non-HDLC and apolipoprotein B as cardiovascular disease risk markers.

  2020cites this paper